Pliant Therapeutics Inc.
10/24/2025 | Press release | Distributed by Public on 10/24/2025 14:33
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 20, 2025, Pliant Therapeutics, Inc. (the "Company") received and accepted the resignation of Hans Hull as Chief Business Officer of the Company, effective that same day. Mr. Hull's resignation was not due to a disagreement on any matter related to the Company's operations, policies or practices.
Pliant Therapeutics Inc. published this content on October 24, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on October 24, 2025 at 20:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]